USCCB Statement on the Supreme Court’s Abortion Pill Decision

| 06/13/2024

By: The Good Newsroom

“Today’s Court ruling on procedural grounds will continue to put the health of women and girls at risk”

Boxes of Mifepristone, the first pill in a medical abortion, are seen at Alamo Women's Clinic in Carbondale, Illinois, April 20, 2023.
Boxes of Mifepristone, the first pill in a medical abortion, are seen at Alamo Women's Clinic in Carbondale, Illinois, April 20, 2023. The U.S. Supreme Court dismissed a challenge to the rules for the availability of the abortion drug mifepristone in a unanimous decision on June 13, 2024. (OSV News photo/Evelyn Hockstein, Reuters)

LOUISVILLE, Kentucky — In response to the decision by the Supreme Court of the United States today on FDA v. Alliance for Hippocratic Medicine the U.S. Conference of Catholic Bishops (USCCB) offered the following statement from its spokesperson, Chieko Noguchi, executive director of public affairs.

“Today’s Court ruling on procedural grounds will continue to put the health of women and girls at risk. As the USCCB’s pro-life chairman has said, abortion is not health care. The Church will continue to advocate for women’s health and safety, and to lovingly serve mothers in need.”

03:12
America's Parish Church choir prepares to lead thousands through the passion, death, and resurrection of Christ.

By:

Mary Shovlain

| 04/02/2026

“Pope Leo XIV made clear: ‘Brothers and sisters, this is our God: Jesus, King of Peace, who rejects war, whom no one can use to justify war,'" the USCCB president said.

By:

The Good Newsroom

| 04/02/2026

The bishop emphasized the USCCB's opposition to the chemical abortion drug not only for its purpose of terminating life, but also that the abortion pill represents an isolating and harmful response to women in need.

By:

The Good Newsroom

| 04/02/2026

Error, group does not exist! Check your syntax! (ID: 7)